Literature DB >> 10712299

Apoptosis in polycystic kidney disease: involvement of caspases.

S M Ali1, V Y Wong, K Kikly, T A Fredrickson, P M Keller, W E DeWolf, D Lee, D P Brooks.   

Abstract

Polycystic kidney disease (PKD) is characterized by the development of large renal cysts and progressive loss of renal function. Although the cause of the development of renal cysts is unknown, recent evidence suggests that excessive apoptosis occurs in PKD. With the use of terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, we have confirmed the presence of apoptotic bodies in cystic kidneys of congenital polycystic kidney (cpk) disease mice carrying a homozygous mutation at 3 wk of age. Apoptosis was localized primarily to the interstitium with little evidence of cell death in cyst epithelium or noncystic tubules. In addition, we observed that the expression of various caspases, bax and bcl-2, was upregulated in cystic kidneys. With the use of various substrates in enzyme activity assays, we have demonstrated a greater than sevenfold increase in caspase 4 activity and a sixfold increase in caspase 3 activity. These data suggest that there is a caspase-dependent apoptosis pathway associated with PKD and support the hypothesis that apoptotic cell death contributes to cyst formation in PKD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712299     DOI: 10.1152/ajpregu.2000.278.3.R763

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  9 in total

1.  Caspase-3 gene deletion prolongs survival in polycystic kidney disease.

Authors:  Yunxia Tao; Iram Zafar; Jun Kim; Robert W Schrier; Charles L Edelstein
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

2.  Role of mitotic, pro-apoptotic and anti-apoptotic factors in human kidney development.

Authors:  Dominko Carev; Dragan Krnić; Marijan Saraga; Damir Sapunar; Mirna Saraga-Babić
Journal:  Pediatr Nephrol       Date:  2006-03-28       Impact factor: 3.714

3.  Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.

Authors:  Yasunori Sato; Kenichi Harada; Kazuo Kizawa; Takahiro Sanzen; Shinichi Furubo; Mitsue Yasoshima; Satoru Ozaki; Masahiko Ishibashi; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

4.  Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

Authors:  Vicki J Hwang; Xia Zhou; Xiaonan Chen; Josephine Trott; Omran Abu Aboud; Kyuhwan Shim; Lai Kuan Dionne; Kenneth J Chmiel; William Senapedis; Erkan Baloglu; Moe R Mahjoub; Xiaogang Li; Robert H Weiss
Journal:  Kidney Int       Date:  2017-05-23       Impact factor: 10.612

5.  Renal pro-apoptotic proteins are reduced by growth hormone resistance but not by visceral fat removal.

Authors:  Adam Gesing; Andrzej Bartke; Feiya Wang; Malgorzata Karbownik-Lewinska; Michal M Masternak
Journal:  Biol Chem       Date:  2011-03-11       Impact factor: 3.915

Review 6.  Molecular Mechanisms of Epigenetic Regulation, Inflammation, and Cell Death in ADPKD.

Authors:  Ewud Agborbesong; Linda Xiaoyan Li; Lu Li; Xiaogang Li
Journal:  Front Mol Biosci       Date:  2022-06-29

7.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

8.  Decreased levels of proapoptotic factors and increased key regulators of mitochondrial biogenesis constitute new potential beneficial features of long-lived growth hormone receptor gene-disrupted mice.

Authors:  Adam Gesing; Michal M Masternak; Andrzej Lewinski; Malgorzata Karbownik-Lewinska; John J Kopchick; Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-11-29       Impact factor: 6.053

9.  Deletion of growth hormone receptor gene but not visceral fat removal decreases expression of apoptosis-related genes in the kidney-potential mechanism of lifespan extension.

Authors:  Adam Gesing; Michal M Masternak; Feiya Wang; Malgorzata Karbownik-Lewinska; Andrzej Bartke
Journal:  Age (Dordr)       Date:  2011-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.